Investing27d
Philip Morris stock rises on FDA's first nicotine pouch approval
Investing.com -- Shares of Philip ... who use cigarettes and/or smokeless tobacco products completely switched to the newly authorized nicotine pouch products. Matthew Farrelly, Ph.D., director ...
business-review.eu15d
Philip Morris International announces that the U.S. Food and Drug Administration have authorized the marketing of ZYN Nicotine Pouch Products
The U.S. Food and Drug Administration (FDA), the US governmental authority responsible for regulating foods and medical products, authorized, on 16 ...
Human Resources Online7d
Q&A: A transformation journey like no other, by Joan Ronquillo-Cuevas, P&C Head for the Asia East Cluster, PMI
Operating in a highly matrixed organisational structure, the Philip Morris International HR leader is committed to delivering ...
Investing6d
Philip Morris International stock jumps on strong Q4 revenue
For 2025, Philip Morris forecasts adjusted EPS of $7.04 to $7.17, representing 7.2% to 9.1% growth over 2024. The company ...
Seeking Alpha24d
High-Yield Heroes - 3 Of The S&P 500's Biggest Payers
While growth is slow due to the secular decline in the traditional cigarette market ... The decline in the chart below shows the Philip Morris (PM) spin-off. This deal did not result in a net ...
Manila Bulletin27d
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
(AP Photo/Bebeto Matthews, File) WASHINGTON (AP) — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help ...
tobaccocontrol.bmj29d
Spinning a global web: tactics used by Big Tobacco to attract children at tobacco points-of-sale
Findings from this monitoring document tobacco marketing tactics that are used by the world’s largest tobacco companies—including British American Tobacco (BAT), Imperial Brands, Japan Tobacco ...